Page 5 - Drug Manufacturers

J&J, other drugmakers go to trial in US in $50 bn case over opioid abuse

J&J, Teva Pharmaceutical Industries Ltd, Endo International Plc and AbbVie's Allergan unit are alleged of fueling a drug crisis that according to the US government resulted in nearly 500,00 deaths

PE firm Advent International acquires 51% stake in ZCL Chemicals

ZCL is one of the fastest-growing manufacturers of specialty active pharmaceutical ingredients (APIs) and advanced intermediates

Shelf life of vaccines likely to be more than 3 months, unlike drugs

They have the stability data for these investigational products, said a source

Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio

Govt revises PLI scheme for bulk drugs to boost local manufacturing

Industry says revised PLI scheme will attract more MSMEs to invest as minimum investment clause done away with

Revised, more industry-friendly PLI scheme for bulk drugs on the cards

Industry says move will mean lower spends and reduced dependence on China

As domestic sales decline, drug makers focus on exports to sustain growth

During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis

CVS raises profit forecast, in talks with US to administer Covid vaccines

CVS also said it was working with laboratories to cut down the turnaround time for coronavirus test results, which had spiked in July due to a massive increase in demand for tests

Govt notifies incentive scheme for local API manufacturing to cut imports

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial

Hyderbad-based drug firm Hetero on Sunday said that it will price its generic version of the drug in the range of Rs 5,000-6,000 per dose

Pvt players must help set up bulk drug, med devices pak: Mandaviya

The minister also said India can progress, if health and hygiene are also included in the overall economic development plan

Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients

Glenmark is conducting phase-3 clinical trials; drug has got restricted emergency use

Revised Wockhardt deal boosts prospects of Dr Reddy's India business

The company, according to its new strategy, is focusing on growing its India-based branded products

Lupin recieves USFDA nod to market generic anthelmintic tablets

According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said

Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study

According to the study, baricitinib also helped reduce the quantity of the novel coronavirus in infected cells

Chennai-based start-up developing Covid-19 remedy, plans to test in US

Patent application filed in India, firm hopes to bring product out in three years

AstraZeneca, Gilead merger likely to hit political, strategic hurdles

Political opposition from both the UK and the US could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak, Citigroup said

Remdesivir pricing in India likely to be lower than global rate: Sources

Indian companies await clarity from the drug regulator on animal toxicology study before they can launch here

Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business

The company has registered 10% growth in revenues at Rs 4,431.8 cr for the quarter under review from Rs 4,016.6 cr in the year-ago period

Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April